Composition for amplifying nucleic acid
The composition for nucleic acid amplification, with optimized DNA polymerase, reverse transcriptase, and primers, addresses the slowness of conventional PCR and the challenges of viral infections, achieving faster and more sensitive real-time PCR operations.
Patent Information
- Application Number
- JP2020061194
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-03-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2040-03-30
AI Technical Summary
Real-time PCR operations are slow due to the heat capacity of aluminum blocks in conventional thermal cyclers, and viral infections require an additional reverse transcription step that interferes with PCR, necessitating a faster and more sensitive method.
A composition for nucleic acid amplification is developed, comprising specific amounts of DNA polymerase, reverse transcriptase, primers, and a fluorescent probe, used in a reciprocal flow type nucleic acid amplification device with a microblower for liquid feeding, enabling faster PCR operations.
The method achieves faster and more sensitive PCR by optimizing primer and reverse transcriptase amounts, allowing real-time monitoring of gene amplification, reducing operation time and enhancing sensitivity.
Smart Images

Figure 0007580877000001 
Figure 0007580877000002
Abstract
Description
[Technical field]
[0001] The present invention relates to a composition for amplifying nucleic acid. [Background technology]
[0002] Real-time PCR is a powerful method that exponentially amplifies genes through thermal cycles, but the general-purpose thermal cycler devices used in real-time PCR have slow temperature control due to the huge heat capacity of the aluminum block that acts as a heater, and traditionally it takes 1 to 2 hours, and sometimes even longer, to perform 30 to 40 PCR cycles. Therefore, even with the latest genetic testing devices, a total analysis usually takes more than an hour, and speeding up PCR operations has been a major challenge since the technology was introduced.
[0003] Under these circumstances, the present inventors developed a reciprocal flow type nucleic acid amplification device that uses a microblower or the like as a liquid delivery mechanism in order to speed up PCR operations (Patent Document 1). [Prior art documents] [Patent documents]
[0004] [Patent Document 1] WO2016 / 006612 Summary of the Invention [Problem to be solved by the invention]
[0005] Quantitation of the amount of target DNA by real-time PCR is useful in clinical practice and is used to confirm the presence or absence of viral infection. However, unlike bacterial infections, viral infections require the step of creating cDNA from purified RNA by reverse transcription, which takes extra time, and the RNA used in cDNA synthesis interferes with the binding of cDNA to primers. Therefore, when performing real-time PCR targeting viral RNA genes, a PCR method that is faster and more sensitive is desired. [Means for solving the problem]
[0006] The present inventors have found that the above problems can be solved by adjusting the amounts of primer and reverse transcriptase added within specific ranges, and have completed the present invention based on this finding. That is, the present invention is as follows. Item 1. A composition for amplifying nucleic acids comprising the following components: (A) DNA polymerase (B) Reverse transcriptase 1.5-4.5U / μL (C) Forward primer 1.2 μM or more (D) Reverse primer: 1.2 μM or more Item 2: The composition for amplifying a nucleic acid according to Item 1, wherein the reverse transcriptase (B) is 1.8 to 4.2 U / μL. Item 3. The composition for amplifying a nucleic acid according to Item 1 or 2, wherein each of the (C) forward primer and the (D) reverse primer is present at 1.5 to 3.5 μM. Item 4. The composition for amplifying a nucleic acid according to any one of Items 1 to 3, comprising 5 to 18 U of (B) reverse transcriptase relative to 1 U of (A) DNA polymerase. Item 5. The composition for amplifying a nucleic acid according to any one of Items 1 to 3, comprising 7 to 16 U of (B) reverse transcriptase relative to 1 U of (A) DNA polymerase. Item 6. The composition for amplifying nucleic acid according to any one of Items 1 to 5, further comprising (E) a fluorescent probe. [Brief description of the drawings]
[0007] [Figure 1] 1 is a diagram showing the configuration of a PCR chip, in which the region enclosed by the dotted line P represents the region where the PCR reaction is carried out, and the region enclosed by the dotted line R represents the region where the reverse transcription reaction is carried out. [Diagram 2]This figure shows the amplification of nucleic acids for RNA having the E gene sequence of SARS-CoV-2 in rapid one-step reverse transcription real-time PCR using different concentrations of reverse transcriptase. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0008] The composition for amplifying nucleic acid of the present invention will be described in detail below.
[0009] The composition for nucleic acid amplification of the present invention is a composition for nucleic acid amplification for performing a PCR reaction after generating cDNA with a reverse transcriptase using RNA as a template. In particular, it is a composition for real-time PCR that can monitor the state of gene amplification during the PCR reaction.
[0010] (A) DNA polymerase The composition for amplifying nucleic acid of the present invention contains a DNA polymerase. In the present invention, the term "DNA polymerase" refers to a heat-resistant DNA polymerase. Examples of the reagent include SpeedSTAR (registered trademark) HS DNA polymerase and ExTaq HS DNA polymerase manufactured by Takara Bio Inc. The DNA polymerase contained in the composition for amplifying nucleic acid of the present invention is 0.15 U / μL or more, preferably 0.15 to 1 U / μL, more preferably 0.18 to 0.75 U / μL, and particularly preferably 0.2 to 0.5 U / μL. Here, the enzyme activity is defined as 1 U, which is the activity that incorporates 10 nmol of total nucleotides into an acid-insoluble precipitate in 30 minutes at 74°C using activated salmon sperm DNA as a template / primer.
[0011] (B) Reverse transcriptase The composition for amplifying nucleic acid of the present invention contains a reverse transcriptase. In the present invention, the term "reverse transcriptase" refers to an enzyme that reverse transcribes genetic information from RNA into DNA, and is used to synthesize cDNA from mRNA molecules using an appropriate oligomer as a primer. Examples of the reagent include PrimeScript (registered trademark) Reverse Transcriptase from Takara Bio Inc. and SuperScript (registered trademark) Reverse Transcriptase from Life Technologies Inc. The reverse transcriptase contained in the composition for amplifying nucleic acid of the present invention is 1.5 to 4.5 U / μL, preferably 1.8 to 4.0 U / μL, more preferably 1.8 to 3.5 U / μL, and particularly preferably 1.8 to 3.5 U / μL. In addition, Poly(rA)·oligo (dT) 12-18 The mixture was incubated at 37°C for 10 min with 1 nmol of [ 3 The enzyme activity that incorporates [H]dTTP is defined as 1U. The composition of the reaction solution for activity measurement is as follows: 50 mM Tris-HCl pH 8.3 75 mM KCl 8 mM MgCl2 10 mM DTT 20 μg / ml (rA)n·(dT) 12-18 0.5 mM 3 H]dTTP 0.1% NP-40 Furthermore, the composition for amplifying nucleic acid of the present invention may contain, for example, 5 to 18 U or 7 to 16 U of reverse transcriptase per 1 U of DNA polymerase.
[0012] (C) Forward primer and (D) reverse primer The composition for amplifying nucleic acid of the present invention includes a primer set. The term "primer set" refers to a combination of a forward primer and a reverse primer, and typically, one type of forward primer and one type of reverse primer are used corresponding to one target gene region. The forward primer and reverse primer contained in the composition for amplifying nucleic acid of the present invention are each at a concentration of 1.2 μM or more, preferably 1.5 to 4.5 μM, more preferably 1.5 to 4.0 μM, and particularly preferably 1.8 to 3.5 μM. The contents of the forward primer and the reverse primer may be the same or different.
[0013] (E) Fluorescent probe When real-time PCR is performed, the composition for amplifying nucleic acid of the present invention preferably contains a fluorescent probe such as a TaqMan probe, a Cycleave probe, or an E probe (registered trademark).
[0014] Examples of dyes (fluorescent dyes) used for fluorescence detection include ABY, acridine, Alexa Fluor 488, Alexa Fluor 532, Alexa Fluor 594, Alexa Fluor 633, Alexa Fluor 647, ATTO (ATTO-TEC fluorescent dye), BioSearch Blue, Cy3, Cy3.5, Cy5, Cy5.5, coumarin, DANSYL, FAM (e.g., 5-FAM, 6-FAM), FITC, GPF, and 5-HEX. , 6-HEX, JOE, JUN, Marina Blue, NED, Oregon Green 488, Oregon Green 500, Oregon Green 514, Pacific Blue, PET, Pulsar, Quasar 570, Quasar 670, Quasar 705, Rhodamine Green, Rhodamine Red, 5-ROX, 6-ROX, 5-TAMRA, 6-TAMRA, 5-TET, 6-TET, Texas Red, TRITC, and VIC.
[0015] The composition for amplifying nucleic acid of the present invention contains other components necessary for PCR reaction. For example, the sample solution contains components necessary for PCR reaction such as various deoxyribonucleotide triphosphates which may be labeled in an aqueous medium mainly composed of water. In addition, buffer components for adjusting pH and salt concentration may be included.
[0016] Real-time PCR using the composition for nucleic acid amplification of the present invention can be carried out, for example, by using a combination of the following nucleic acid amplification device and nucleic acid amplification chip.
[0017] [Nucleic acid amplification device] A heater that can create a denaturation temperature zone and an extension / annealing temperature zone. a fluorescence detector capable of measuring the fluorescence intensity of a sample liquid present in a microchannel; a liquid transfer mechanism that enables the movement of the sample liquid between the two temperature zones and is released to atmospheric pressure when liquid transfer is stopped; A substrate on which a nucleic acid amplification chip can be mounted; a control mechanism for controlling the driving of the liquid delivery mechanism in response to an electrical signal from the fluorescence detector relating to the movement of the sample liquid; A reciprocal flow type nucleic acid amplification device that performs real-time PCR by measuring the fluorescence intensity for each thermal cycle.
[0018] [Nucleic acid amplification chip] The nucleic acid amplification chip has at least one microchannel having curved flow channels corresponding to the denaturation temperature zone and the extension / annealing temperature zone, respectively, a straight or curved intermediate flow channel connecting the curved flow channels, and a connection portion at one or both ends of the flow channel that can be connected to a liquid delivery mechanism in the nucleic acid amplification device.
[0019] Specifically, this can be carried out by the following steps 1 to 4: Step 1: placing the nucleic acid amplification chip on a substrate of the nucleic acid amplification device; Step 2: connecting the liquid delivery mechanism to a liquid delivery mechanism connection part at one or both ends of the microchannel; Step 3: A step of performing thermal cycling by moving the sample liquid back and forth between the two curved flow paths of the micro flow path using the liquid delivery mechanism. Step 4: A step of measuring the fluorescence intensity of the sample liquid for each thermal cycle by the fluorescence detector at a predetermined position in the flow channel.
[0020] The microchannel is preferably made of a material that satisfies some or all of the following requirements: (i) relatively high thermal conductivity, (ii) stability in the temperature range required for PCR, (iii) resistance to corrosion by electrolyte solutions and organic solvents, and (iv) low adsorption of nucleic acids and proteins. Specific examples include glass, quartz, silicon, and various thermosetting and photosetting resins such as cycloolefin polymer (COP). From the viewpoint of performing fluorescence detection, the material is preferably transparent and has high light (especially excitation light and emitted light for performing fluorescence detection) transmittance (i.e., little absorption, diffusion, reflection, etc.).
[0021] The microchannel may have a structure in which a groove is formed in a material by a method such as machining such as cutting by NC machining, injection molding, nanoimprinting, soft lithography, or the like, and sealed with a seal (preferably a transparent seal made of polyolefin, for example). Alternatively, the microchannel may be formed by three-dimensional printing. The cross-sectional shape of the microchannel is not particularly limited, and may be a semicircular shape, a circular shape, a rectangular shape, a wedge shape, a trapezoid shape, a polygonal shape, or the like. The cross-section of the microchannel may have a width of about 10 to 1000 μm and a depth of about 10 to 1000 μm, for example. The width and depth of the microchannel may each be constant, or the width or depth may vary partially.
[0022] The shape of the curved flow channel corresponding to the denaturation temperature zone and the curved flow channel corresponding to the elongation / annealing temperature zone of the microchannel can be a meandering flow channel having a loop shape, a spiral flow channel, etc. The intermediate flow channel connecting the curved flow channel corresponding to the denaturation temperature zone and the curved flow channel corresponding to the elongation / annealing temperature zone can be either linear or curved.
[0023] The length of each of the curved flow channel corresponding to the denaturation temperature zone and the curved flow channel corresponding to the extension / annealing temperature zone is preferably 20 mm or more.
[0024] The curved flow path corresponding to the denaturation temperature zone and the curved flow path corresponding to the extension / annealing temperature zone of the microchannel are each maintained at a corresponding temperature, and the temperature of the sample liquid that has moved into that temperature zone is changed to the temperature of that temperature zone.
[0025] The denaturation temperature zone is maintained at a temperature necessary for the DNA denaturation reaction in PCR. The temperature of the denaturation temperature zone is preferably about 90 to 100°C, and more preferably about 95°C. The extension / annealing temperature zone is maintained at a temperature necessary for the DNA annealing reaction and extension reaction in PCR. The temperature of the extension / annealing temperature zone is preferably about 40 to 75°C, and more preferably about 55 to 65°C.
[0026] Each of the denaturation temperature zone and the extension / annealing temperature zone is preferably maintained at a constant temperature. The temperature can be maintained by a heat source. The heat source is, for example, built into the microchannel or in contact with the microchannel. Specific examples of the heat source include a cartridge heater, a film heater, a Peltier heater, and the like.
[0027] In the nucleic acid amplification method of the present invention, the sample liquid moves in the microchannel in the form of a plug. The volume of the sample liquid moving in the microchannel is not particularly limited, and may be preferably about 5 to 50 μL, more preferably about 15 to 20 μL.
[0028] In the nucleic acid amplification method of the present invention, the movement of the sample liquid is realized by a liquid delivery mechanism that is released to atmospheric pressure when liquid delivery is stopped. That is, instead of using a mechanism that requires the inside of the flow channel to be a closed system so that the pressure of a syringe pump or the like does not escape, a liquid delivery mechanism that is configured to form an open system even during liquid delivery is used. By employing such a liquid delivery mechanism, when the air delivery is stopped, the pressure inside the flow channel is instantly released to atmospheric pressure, and the pressure acting on the plug-shaped sample liquid is lost, so that the liquid delivery immediately stops. Therefore, accurate position control is possible even without multiple pressure release valves for controlling the position of the sample liquid.
[0029] Examples of the liquid delivery mechanism that is released to atmospheric pressure when liquid delivery is stopped include a microblower and a fan.
[0030] A microblower (also called a piezoelectric microblower) is a known device that draws in and discharges air, and is characterized by not having a sealed structure (having no check valve). In a typical microblower, the diaphragm is bent and deformed by applying a voltage to a piezoelectric element, thereby achieving the drawing in and discharge of air. As a microblower, for example, those manufactured by Murata Manufacturing Co., Ltd. can be used (MZB1001T02, MZB3004T04).
[0031] A fan is a device that blows air by the rotational motion of an impeller. Due to the structural characteristics of the impeller, the flow path is not a closed system.
[0032] Thermal cycling is performed by repeating the above cycle at least once, preferably about 30 to 50 times, and more preferably about 35 to 50 times. The number of cycles can be appropriately set depending on the concentration of the template nucleic acid, the type of the target gene, etc.
[0033] The time for which the sample liquid is held in the denaturation temperature zone and the time for which the sample liquid is held in the extension / annealing temperature zone can each be appropriately set according to the target gene region (type of gene, length of region, etc.) For example, the time for which the sample liquid is held in the denaturation temperature zone can be about 2 to 10 seconds, and the time for which the sample liquid is held in the extension / annealing temperature zone can be about 2 to 60 seconds.
[0034] The liquid delivery mechanism is connected to the microchannel via, for example, a connection portion.
[0035] The present invention will be described in detail below with reference to examples, but the scope of the present invention is not limited to these examples.
[0036] [Example] Quantification of SARS-CoV-2 Using a PCR chip for high-speed real-time PCR (Figure 1) and a real-time PCR device with a microblower as a liquid delivery mechanism described in WO2016 / 006612, the target gene of the new coronavirus (SARS-CoV-2) was quantified. High-speed real-time PCR was performed using the E genome RNA gene of SARS-CoV-2 prepared at 10,000 copies / μl as a template, and mixing sterilized water instead as a negative control (NTC).
[0037] The following primer and probe sequences were used for the targets: the forward primer sequence for the E gene was 5'-ACAGGTACGTTAATAGTTAATAGCGT-3' (SEQ ID NO: 1), the reverse primer sequence was 5'-ATATTGCAGCAGTACGCACACA--3' (SEQ ID NO: 2), and the TaqMan® probe sequence was 5'-ACACTAGCCATCCTTACTGCGCTTCG-3' (SEQ ID NO: 3).
[0038] The fluorescent probes for SARS-CoV-2 were Cy5-labeled TaqMan® probes, each with a final concentration of 200 nM in the PCR solution.
[0039] The final concentrations of the forward primer and reverse primer in the PCR solution were each 2 μM. As the DNA polymerase, SpeedSTAR (registered trademark) HS DNA polymerase from Takara Bio Inc. was used at a final concentration of 0.25 U / μL. As the reverse transcriptase, PrimeScript RT enzyme Mix II was used at a final concentration of 2 to 5 U / μL.
[0040] The thermal cycle conditions for the reverse transcription reaction were 42° C. for 30 seconds, followed by a hot start of 96° C. for 10 seconds, followed by 50 cycles of 96° C. for 5 seconds and 58° C. for 8 seconds.
[0041] The fluorescence intensity of SARS-CoV-2 using rapid real-time PCR was inhibited by a final reverse transcriptase concentration of 5 U / μL, as shown in Figure 2. On the other hand, in a PCR reaction solution containing 2 μM each of forward primer and reverse primer, PCR could be performed quickly and sensitively when the reverse transcriptase was 2, 3, or 4 U / μL.
Claims
1. below (A) DNA polymerase (B) Reverse transcriptase 1.5 to 4.5 U / μL (C) Forward primer: 1.2 μM or more (D) Reverse primer: 1.2 μM or more (E) Fluorescent probe wherein (A) is 1 U and (B) is 5 to 18 U.
2. A composition for amplifying nucleic acid as described in claim 1, wherein (B) is 7 to 16 U per 1 U of (A).
3. 3. The composition for amplifying a nucleic acid according to claim 1, wherein each of the forward primer (C) and the reverse primer (D) is 1.5 to 3.5 μM.
Citation Information
Patent Citations
Method and kit for detecting porcine reproductive and respiratory syndrome virus live vaccine strain JXA1-R
CN103498008A
Composition, reagent kit and method for detecting feline infectious peritonitis virus
CN110724768A
high temperature reverse transcriptase
JP1993505105A
Extreme Reverse Transcription PCR
JP2018538007A
Nucleic acid amplification device, nucleic acid amplification method, and chip for nucleic acid amplification
WO2016006612A1
